9. Downstream Health and Economic Outcomes of Pembrolizumab in the Treatment of NSCLC and Melanoma in Italy

Università Tor Vergata, CEIS-Economic Avaluation and HTA (EEHTA) Via Columbia 2, 00133 Rome, Italy

segreteria.rome@isporitaly.org

Linkedin

©Copyright 2025 | ISPOR Italy – Rome Regional Chapter | C.F. 97803280581 | Privacy Policy